Biotech · Public company · Watertown, MA, US
Neumora Therapeutics, Inc.
Ticker NMRA · SEC CIK 0001885522
Track this companyFree. Adds Neumora Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline3
- NMRA-335140Phase 3 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- NMRA-335140 80 mgPhase 2 · Major Depressive Episode Associated With Bipolar II DisorderClinicalTrials.gov · fetched Nov 12, 2026
- NMRA-323511Phase 1 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's DiseasePHASE1 · COMPLETED · started Jul 9, 2024ClinicalTrials.gov NCT06546995 · fetched Nov 12, 2026
- To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.PHASE2 · COMPLETED · started May 13, 2024ClinicalTrials.gov NCT06429722 · fetched Nov 12, 2026
- Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderPHASE3 · COMPLETED · started Dec 21, 2023ClinicalTrials.gov NCT06058039 · fetched Nov 12, 2026
- Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderPHASE3 · COMPLETED · started Dec 20, 2023ClinicalTrials.gov NCT06058013 · fetched Nov 12, 2026
- Study to Assess the Safety and Effectiveness of NMRA-335140-501PHASE3 · TERMINATED · started Nov 10, 2023ClinicalTrials.gov NCT06029439 · fetched Nov 12, 2026
- Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderPHASE3 · COMPLETED · started Sep 20, 2023ClinicalTrials.gov NCT06029426 · fetched Nov 12, 2026
- Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs PlaceboPHASE2 · COMPLETED · started Jan 3, 2020ClinicalTrials.gov NCT04221230 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Oct 30, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 29, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 12, 2026 · fetched Nov 12, 2026